推荐产品
化驗
≥98% (HPLC)
形狀
solid
顏色
off-white
溶解度
H2O: 19 mg/mL
起源
Endo
SMILES 字串
CCC1=C(C)NC2=C1C(C(CN3CCOCC3)CC2)=O.Cl
InChI
1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H
InChI 密鑰
GQWNECFJGBQMBO-UHFFFAOYSA-N
基因資訊
human ... DRD2(1813) , HTR2A(3356) , MAOA(4128) , MAOB(4129)
正在寻找类似产品? 访问 产品对比指南
生化／生理作用
D2 dopamine receptor antagonist; MAO inhibitor.
特點和優勢
This compound was developed by Endo. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
訊號詞
Danger
危險聲明
防範說明
危險分類
Acute Tox. 3 Oral
儲存類別代碼
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Aripiprazole-induced agitation after clozapine discontinuation: a case report.
Dara Y Cho et al.
The Journal of clinical psychiatry, 70(1), 141-143 (2009-02-19)
Robert L Findling et al.
Journal of the American Academy of Child and Adolescent Psychiatry, 49(6), 583-594 (2010-05-25)
To examine the long-term safety and efficacy of three antipsychotics in early-onset schizophrenia spectrum disorders. Patients (8 to 19 years old) who had improved during an 8-week, randomized, double-blind acute trial of olanzapine, risperidone, or molindone (plus benztropine) were eligible
M Froimowitz et al.
Drug design and discovery, 15(2), 63-81 (1997-08-01)
This study is an attempt to incorporate the butyrophenones, an important class of nontricyclic antipsychotic drugs, into a previously proposed pharmacophore model of tricyclic dopamine D2 receptor antagonist ligands. Conformational energy calculations were performed using the MM3-92 program on spiperone
H B Pinkofsky
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 9(3), 175-179 (1997-10-27)
The onset of psychosis during pregnancy presents several difficult management decisions and a careful risk-benefit analysis is required. Withholding antipsychotic treatment may produce more risks than benefits. Studies on neuroleptic teratogenicity are contradictory. Most of the commonly used neuroleptics exhibit
C Recasens
L'Encephale, 27(3), 269-276 (2001-08-08)
Weight gain associated with neuroleptics or antipsychotic treatment is well known by psychiatrists, but is too rarely considered as justifying a specific treatment program. Overweight is a risk factor for somatic disorders and can have a negative influence on self-esteem
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门